Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06495918
What this trial is testing

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Ocular Therapeutix, Inc. 825
Testing effectiveness (Phase 2)Study completedNCT04832724
What this trial is testing

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular DegenerationWet Age-related Macular Degeneration
AbbVie 60
Testing effectiveness (Phase 2)Ended earlyNCT02348359
What this trial is testing

X-82 to Treat Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (AMD)Macular DegenerationExudative Age-related Macular Degeneration+5 more
Tyrogenex 157
Testing effectiveness (Phase 2)Study completedNCT02510794
What this trial is testing

Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Genentech, Inc. 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT04514653
What this trial is testing

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AbbVie 146
Testing effectiveness (Phase 2)Study completedNCT04567303
What this trial is testing

Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Hoffmann-La Roche 177
Not applicableStudy completedNCT01526070
What this trial is testing

Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Stanford University 142
Post-approval studies (Phase 4)Study completedNCT05710471
What this trial is testing

Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E

Who this might be right for
Age-Related Macular Degeneration
The University of Hong Kong 30
Testing effectiveness (Phase 2)Study completedNCT03744767
What this trial is testing

Adjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Dr Irmela MANTEL 20
Not applicableStudy completedNCT03679156
What this trial is testing

Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term Treatment With Anti Neovascular Endothelial Growth Factor

Who this might be right for
Neovascular Age-related Macular Degeneration
Hospital Hietzing 18
Early research (Phase 1)UnknownNCT03675880
What this trial is testing

TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects

Who this might be right for
AMD
Lee's Pharmaceutical Limited 24
Not applicableUnknownNCT00640640
What this trial is testing

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Sheba Medical Center 60
Early research (Phase 1)Study completedNCT03630315
What this trial is testing

CLN-0046: Treatment of AMD Subjects With OTX-TKI

Who this might be right for
Neovascular Age-related Macular Degeneration
Ocular Therapeutix, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT03066258
What this trial is testing

Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial

Who this might be right for
Neovascular Age-related Macular DegenerationWet Age-related Macular Degeneration
REGENXBIO Inc. 42
Early research (Phase 1)Looking for participantsNCT05803785
What this trial is testing

Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Age-Related Macular Degeneration
Benobio Co., Ltd. 18
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Not applicableStudy completedNCT01306591
What this trial is testing

Bevacizumab for Neovascular Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Peking University People's Hospital 210
Not applicableEnded earlyNCT00902785
What this trial is testing

Early Markers Of Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization (CNV)Age-related Macular Degeneration (AMD)Early Markers
Pfizer 100
Early research (Phase 1)Study completedNCT01033721
What this trial is testing

Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Paloma Pharmaceuticals, Inc. 13
Post-approval studies (Phase 4)UnknownNCT00813891
What this trial is testing

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationVisual Acuity
McGill University Health Centre/Research Institute of the McGill University Health Centre 180
Next Page